PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$22.40M
Total Shares
1.08M
Net Share Change
-714.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$22.40M1.08M shares
TRIM-714.3K(-39.9%)